FDA approves Izervay for geographic atrophy tied to age-related macular degeneration
Aug 09, 2023
Two trials show significant slowing of geographic atrophy progression at the 12-month primary end point.
Living with low vision: AMD
By
Aaron Tutwiler
Sep 28, 2023
seniors living with AMD and other vision issues have a plethora of options available, from injectable treatments to assistive technologies and other developing medications.